NCT06974708 Interactive Virtual Occupational Safety Training Designed for Home Healthcare Workers
| NCT ID | NCT06974708 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ohio State University |
| Condition | Learning |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2025-04-17 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2025-04-17 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Overview. The investigators will collect preliminary data on the extent to which the knowledge gained from the enhanced HH-VSTS transfers to a real-world environment. Following abbreviated use of the enhanced HH-VSTS, participants will perform a walk-through of a realistic environment to assess their learning.
Eligibility Criteria
Inclusion Criteria: * have no formal training in home safety, and * ≥18 years old, and * able to read and write in English. Exclusion Criteria: * Participant in a prior study about home healthcare worker occupational safety training * Individuals who meet criteria for Pre-existing Conditions Related to Cybersickness (a set of 4 screening questions)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06974708 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Learning. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06974708 currently recruiting?
Yes, NCT06974708 is actively recruiting participants. Contact the research team at sommerich.1@osu.edu for enrollment information.
Where is the NCT06974708 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT06974708 clinical trial?
NCT06974708 is sponsored by Ohio State University. The trial plans to enroll 24 participants.